DOI:

Paclitaxel-eluting stent restenosis shows three-layer appearance by optical coherence tomography

Shuzou Tanimoto, MD; Jiro Aoki, MD; Patrick W. Serruys, MD, PhD; Evelyn Regar*, MD, PhD

A 73-year-old woman with hypertension, hyperlipidemia and positive familial history of coronary artery disease presented with Canadian Cardiovascular Society class III angina and underwent coronary angiography, which showed a chronic occluded right coronary artery (Panel A). The vessel was recanalized and treated with three paclitaxel-eluting stents (TAXUS®, Boston Scientific: 3.5 x 32 mm distally, 3.5 x 28 mm in the middle part, 3.5 x 12 mm proximally). Postintervention coronary angiography showed a good result (Panel B). Twelve-month follow-up angiography revealed focal in-stent restenosis (Panel C). Intracoronary optical coherence tomography (OCT: LightLabImaging™, Boston, MA, USA) pullback displayed well-expanded stents covered with a thin, homogenous, highly reflective neointimal layer (Panel D, E). In contrast, the narrowest lesion site (minimal lumen area 1.1 mm2; stent area 9.0 mm2) showed a three-layer appearance of the neointima (Panel F). The inner luminal layer appeared concentric, homogenous and signal-rich (maximal thickness 0.27 mm). A second layer consisting of a low-reflective area with poorly delineated borders followed. The third layer was in direct contact with the stent struts and revealed only minimal signal intensity. These signal-poor areas (maximal thickness 1.18 mm) might represent acellular fibrinoid deposition that has been well described in experimental studies. The patient was re-treated with repeat paclitaxel-eluting stent implantation.

OCT is an analogue of intravascular ultrasound with an ultra-high resolution (10 µm) superior to any current available imaging modalities. This imaging device may be useful in visualizing neointimal growth in drug-eluting stents and improve our understanding of its underlying physiopathology in the future.

Volume 1 Number 4
Feb 20, 2006
Volume 1 Number 4
View full issue


Key metrics

Suggested by Cory

Flashlight

10.4244/EIJ-D-25-00341 Jan 8, 2026
Retrieval of a stuck transcatheter aortic valve device via left ventricular apex and transapical implantation
Yasuda M et al
open access

Editorial

10.4244/EIJ-E-25-00053 Jan 5, 2026
The quiescent volcanoes that don't harm anymore
Prati F and Biccirè F
free

Editorial

10.4244/EIJ-D-25-01153 Jan 5, 2026
Computed tomography angiography-derived microvascular resistance: is less always more?
Gallinoro E and Barbato E
free

Editorial

10.4244/EIJ-E-25-00051 Jan 5, 2026
QFR in clinical practice: raising the bar for quality and reproducibility
Lansky A
free

Viewpoint

10.4244/EIJ-D-25-01167 Jan 5, 2026
High-risk plaques: intervene early or hold the line?
Mintz G and Collet C
free

Expert Review

10.4244/EIJ-D-25-00263 Jan 5, 2026
Endomyocardial biopsy
Fabris E et al
free

Original Research

10.4244/EIJ-D-25-00648 Jan 5, 2026
Long-term clinical outcomes of non-culprit plaque rupture in STEMI
Zhao J et al

Original Research

10.4244/EIJ-D-25-00671 Jan 5, 2026
Non-invasive assessment of microcirculatory resistance by coronary computed tomography angiography
Deng D et al
open access

Original Research

10.4244/EIJ-D-25-00668 Jan 5, 2026
Repeatability and quality assessment of QFR in the FAVOR III Europe trial: the REPEAT-QFR study
Kristensen S et al
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved